Norstella recently spoke with the Wall Street Journal’s Brian Gormley in a feature article: Biotech VC’s Vaccine Die-Hards. The piece explores how investment has pivoted away from vaccines, leaving a
Rare Disease Day will be commemorated on 28 February this year, as it has been every year since 2008. Coordinated by EURORDIS-Rare Diseases Europe, the day will bring together over
In the first few weeks following the launch of oral semaglutide, early prescription activity answered a familiar question: Uptake was occurring and growing exponentially within a matter of weeks. But
The Norstella Panel puts you in the room with the people who decide. Active P&T leaders. Payer and PBM decision makers. Provider and IDN influencers. The voices shaping coverage in
As real-world data (RWD) evolves, the rise of unstructured data—from clinical notes to lab reports—is transforming how life sciences teams identify, understand, and engage with patients and providers. These data
Real-world data (RWD) and Artificial Intelligence (AI) are evolving fast, and with the integration of unstructured data, large language models
In October 2025, Norstella brought together key leaders in the pharmaceutical space and Norstella’s top RWD/AI experts for a day
Innovation at Norstella often begins with a question: What if we could move faster—without sacrificing quality or compliance? During a
As clinical trials increase in number and complexity, so does the competition for the patients best aligned to the study
Real-world data (RWD) is transforming the life sciences industry, giving pharma companies valuable insights into the patient journey and helping
Dan Chancellor, VP, Thought Leadership, Lance Wolkenbrod, Senior Principal, RWD Solutions, and Dr. Madeline Naylor, Chief Clinician, at Norstella discuss